ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.82, $0.18 better than the analyst estimate of $1.64. Revenue for the quarter came in at $340.5 million versus the consensus estimate of $319.9 million.

GUIDANCE:

ICU Medical sees FY2022 EPS of $9.00-$10.50, versus the consensus of $9.26.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.